SCM Lifescience Statistics

Total Valuation

SCM Lifescience has a market cap or net worth of KRW 30.89 billion. The enterprise value is 32.66 billion.

Market Cap	30.89B
Enterprise Value	32.66B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

SCM Lifescience has 20.47 million shares outstanding. The number of shares has increased by 37.71% in one year.

Current Share Class	n/a
Shares Outstanding	20.47M
Shares Change (YoY)	+37.71%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	17.03%
Owned by Institutions (%)	n/a
Float	16.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	34.75
PB Ratio	2.62
P/TBV Ratio	2.81
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.09
EV / Sales	36.72
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.49

Financial Position

The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.34.

Current Ratio	1.27
Quick Ratio	0.84
Debt / Equity	0.34
Debt / EBITDA	n/a
Debt / FCF	-0.31
Interest Coverage	-66.14

Financial Efficiency

Return on equity (ROE) is -79.38% and return on invested capital (ROIC) is -30.91%.

Return on Equity (ROE)	-79.38%
Return on Assets (ROA)	-28.21%
Return on Capital (ROIC)	-30.91%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.03
Inventory Turnover	1.08

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.88% in the last 52 weeks. The beta is 1.16, so SCM Lifescience's price volatility has been higher than the market average.

Beta (5Y)	1.16
52-Week Price Change	-50.88%
50-Day Moving Average	1,883.90
200-Day Moving Average	2,353.35
Relative Strength Index (RSI)	33.35
Average Volume (20 Days)	494,049

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SCM Lifescience had revenue of KRW 889.44 million and -15.65 billion in losses. Loss per share was -763.98.

Revenue	889.44M
Gross Profit	412.04M
Operating Income	-11.69B
Pretax Income	-15.65B
Net Income	-15.65B
EBITDA	-10.89B
EBIT	-11.69B
Loss Per Share	-763.98

Full Income Statement

Balance Sheet

The company has 2.28 billion in cash and 4.06 billion in debt, giving a net cash position of -1.78 billion or -86.78 per share.

Cash & Cash Equivalents	2.28B
Total Debt	4.06B
Net Cash	-1.78B
Net Cash Per Share	-86.78
Equity (Book Value)	11.79B
Book Value Per Share	576.07
Working Capital	764.19M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -11.27 billion and capital expenditures -1.85 billion, giving a free cash flow of -13.12 billion.

Operating Cash Flow	-11.27B
Capital Expenditures	-1.85B
Free Cash Flow	-13.12B
FCF Per Share	-641.01

Full Cash Flow Statement

Margins

Gross Margin	46.33%
Operating Margin	-1,313.92%
Pretax Margin	-1,759.22%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SCM Lifescience does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.71%
Shareholder Yield	-37.71%
Earnings Yield	-50.63%
FCF Yield	-42.48%

Stock Splits

The last stock split was on September 15, 2023. It was a forward split with a ratio of 1.2.

Last Split Date	Sep 15, 2023
Split Type	Forward
Split Ratio	1.2

Scores

SCM Lifescience has an Altman Z-Score of -10.56. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-10.56
Piotroski F-Score	n/a